SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-24-044442
Filing Date
2024-04-08
Accepted
2024-04-08 06:04:51
Documents
17
Period of Report
2024-04-08
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2411301d1_8k.htm   iXBRL 8-K 32074
2 EXHIBIT 99.1 tm2411301d1_ex99-1.htm EX-99.1 17070
7 GRAPHIC image_002.jpg GRAPHIC 3061
8 GRAPHIC image_003.jpg GRAPHIC 6423
  Complete submission text file 0001104659-24-044442.txt   289870

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA zura-20240408.xsd EX-101.SCH 3257
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE zura-20240408_def.xml EX-101.DEF 26908
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE zura-20240408_lab.xml EX-101.LAB 36516
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE zura-20240408_pre.xml EX-101.PRE 25532
20 EXTRACTED XBRL INSTANCE DOCUMENT tm2411301d1_8k_htm.xml XML 5582
Mailing Address 4225 EXECUTIVE SQUARE SUITE 600 LA JOLLA CA 92037
Business Address 4225 EXECUTIVE SQUARE SUITE 600 LA JOLLA CA 92037 858-247-0520
Zura Bio Ltd (Filer) CIK: 0001855644 (see all company filings)

IRS No.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40598 | Film No.: 24828015
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)